- Home
- ONCY vs SILC Comparison
ONCY vs SILC Comparison
Compare ONCY & SILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- SILC
- Stock Information
- Founded
- ONCY 1998
- SILC 1987
- Country
- ONCY Canada
- SILC Israel
- Employees
- ONCY N/A
- SILC N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- SILC Computer Manufacturing
- Sector
- ONCY Health Care
- SILC Technology
- Exchange
- ONCY Nasdaq
- SILC Nasdaq
- Market Cap
- ONCY 89.7M
- SILC 99.6M
- IPO Year
- ONCY 1999
- SILC 1994
- Fundamental
- Price
- ONCY $1.11
- SILC $16.74
- Analyst Decision
- ONCY Strong Buy
- SILC Hold
- Analyst Count
- ONCY 5
- SILC 1
- Target Price
- ONCY $5.00
- SILC N/A
- AVG Volume (30 Days)
- ONCY 900.3K
- SILC 25.9K
- Earning Date
- ONCY 11-07-2025
- SILC 10-30-2025
- Dividend Yield
- ONCY N/A
- SILC N/A
- EPS Growth
- ONCY N/A
- SILC N/A
- EPS
- ONCY N/A
- SILC N/A
- Revenue
- ONCY N/A
- SILC $59,509,000.00
- Revenue This Year
- ONCY N/A
- SILC $6.53
- Revenue Next Year
- ONCY N/A
- SILC $14.10
- P/E Ratio
- ONCY N/A
- SILC N/A
- Revenue Growth
- ONCY N/A
- SILC N/A
- 52 Week Low
- ONCY $0.33
- SILC $12.29
- 52 Week High
- ONCY $1.51
- SILC $19.37
- Technical
- Relative Strength Index (RSI)
- ONCY 39.70
- SILC 46.53
- Support Level
- ONCY $1.16
- SILC $15.19
- Resistance Level
- ONCY $1.32
- SILC $18.59
- Average True Range (ATR)
- ONCY 0.07
- SILC 0.64
- MACD
- ONCY -0.01
- SILC -0.11
- Stochastic Oscillator
- ONCY 10.42
- SILC 45.59
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About SILC Silicom Ltd
Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, FPGA-Based Cards, x86 Open Appliances, Bypass Switches, and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.